- Home
- RNAC vs DOUG Comparison
RNAC vs DOUG Comparison
Compare RNAC & DOUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNAC | DOUG |
|---|---|---|
| Founded | 2007 | 1911 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.3M | 162.3M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RNAC | DOUG |
|---|---|---|
| Price | $6.82 | $1.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | 166.1K | ★ 524.2K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 118.68 |
| EPS | N/A | ★ 0.17 |
| Revenue | $2,797,000.00 | ★ $955,578,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.38 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.60 | $1.53 |
| 52 Week High | $14.56 | $3.20 |
Technical Indicators
Market Signals| Indicator | RNAC | DOUG |
|---|---|---|
| Relative Strength Index (RSI) | 51.92 | 56.55 |
| Support Level | $6.54 | $1.55 |
| Resistance Level | $7.81 | $2.87 |
| Average True Range (ATR) | 0.45 | 0.08 |
| MACD | 0.12 | 0.05 |
| Stochastic Oscillator | 57.01 | 88.00 |
Price Performance
Historical ComparisonAbout RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is engaged in the real estate services business and seeks to acquire or invest in additional real estate services businesses. The Company also offers, through its subsidiaries and ventures, development marketing services and ancillary services, including mortgage, title, and escrow services. It generates revenue from commissions and other brokerage income, property management, and other ancillary services.